GSK Initiates First Global Phase III Study Of Tykerb® (Lapatinib) In Head And Neck Cancer

Mon, 26 Feb 2007 09:00 PM EST

... GlaxoSmithKline today announced the start of an international Phase III trial of its investigational cancer treatment Tykerb® (lapatinib) in squamous cell carcinoma of the head and neck (SCCHN). [click link for full article] ...